FDA Investigator Jackson Y See
Jackson Y See has inspections in 3 countries as of 26 Mar 2024. Jackson Y See has collaborated with a combined 1728 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
26 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Dominican Republic
Co-Investigator(s):
Albert Thompson,
Alice S Tsao,
Alysia M Salonia,
Amber D Brodas,
Amy Kim,
Andrew Cohen,
Andrew F Cohen,
Andrew J Garufi,
Andrew J Seaborn,
Ann B Okon,
Anthony R Rauert,
Anthony W Thomas,
Ashley Defilippis,
Ashley Polizzotto,
Betty M Ng Lee,
Brandon J Kocurek,
Carrie E Jolly,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
David R Lattuca,
Debra D Devlieger,
Devon O Seymour,
Donald J Ullstrom,
Donald Ullstrom,
Elizabeth H Davis,
Elizabeth H Slazak,
Emily J Schramm,
Eric J Reisenauer,
Eufemia G Gonzalez,
Gray,
Irina Gaberman,
Isaac K Carney,
Jane Chen,
Jennifer L Custodio,
Joanne M Schlossin,
Joel R Merriman,
John L Zaccone,
John P Sakowski,
Joseph J Vannelli,
Joseph Maselli,
Joseph T Frost,
Joshua D Lopez,
Joy A Matthias,
Joy P Matthias,
Joyce A Kellett,
Joyce A Williams,
Juan C Gonzalez,
Judy Keihl,
Juliana Falla,
Kevin A Gonzalez,
Kristen C Jackson,
Kristen M Campbell,
Leroy Terrelonge,
Linda M Sacco,
LTJG Matthew R Palo,
Manhar Patel,
Manhar R Patel,
Mark E Farrell,
Marlene L Davis,
Mecado,
Melinee C Minhas,
Melissa N Gregorio,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael R Dominick,
Michael W Burd,
Michelle M Noe,
Morgan J Matthews,
Nichole B Murphy,
Pamela L Ogonowski,
Patty P Kaewussdangkul,
Pearl L Gonzalez,
Perez,
Peter M Trunk,
Peter R Caparelli,
Rachael A Moliver,
Raymond M Lam,
Richard L Licari,
Robert E Moncayo,
Ronald Ifraimov,
Rupa Pradhan,
Samuel A Francis,
Shantel S Brown,
Siobhan A Gallagher,
Slater K Bartlett,
Sonia E Ortiz,
State Agency,
Steven B Chiu,
Sunita Vij,
Thomas N Adjabeng,
Thomas Siebertz,
Tracy M Portelli,
Troy R Petrillo,
Valerie A Potopsingh,
Wendy A Johnecheck,
Weston K Szymanski,
Yuyan Liang,
Yvonne M Santiago,
Zameer Farouk
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more